|
|
FDA Clears Technology to Aid to Concussion Diagnosis
October 18, 2021
 |
The U.S. Food and Drug Administration recently granted clearance of the EYE-SYNC technology as an Aid to Concussion or mild traumatic brain injury diagnosis. This is the first FDA-approved mobile, rapid test for concussion and was created by... |
|
 Continue reading (Members only)
|
|
Methamphetamine Use, Overdose Deaths From Psychostimulants Are Increasing
October 14, 2021
 |
It is estimated that from 2015 to 2019, the number of overdose deaths from psychostimulants other than cocaine (namely methamphetamines) has more than doubled. In this cross-sectional study involving nearly 200,000 individuals aged 18-64, the authors sought to uncover some of the factors associated with this increase in overdose deaths from methamphetamines... |
|
Continue reading (Members only)
|
|
|
|
Insulin Resistance Linked to Major Depressive Disorder
October 7, 2021
 |
Major depressive disorder is often difficult to predict yet is the leading cause of disability worldwide. A growing body of literature suggests that metabolic parameters may influence the development or worsening of depression. In this longitudinal study of nearly... |
|
Continue reading (Members only)
|
|
|
|
ADHD and Alzheimer’s Disease Across Generations
September 25, 2021
 |
Due to previous conflicting results regarding the association between attention-deficit hyperactivity disorder (ADHD) and Alzheimer’s disease (AD), a recent nationwide cohort study evaluated their link across generations. Index persons (N=2,132,929) born in Sweden were linked to their biological relatives: 4,246,182 index person-parent pairs.... |
|
Continue reading (Members only)
|
|
Early Life Risk Markers for Psychiatric Disorders
September 21, 2021
 |
The consequences of preschool-age irritability on long-term functioning have not been well-studied. A recent study examined longitudinal associations of preschool irritability with psychiatric disorders and functional impairment in adolescence in a large community sample. In this study, 453 children were assessed at age.... |
|
Continue reading (Members only)
|
|
FDA-Approved First Treatment for Idiopathic Hypersomnia
September 16, 2021
|
The US Food and Drug Administration (FDA) has just approved the first treatment for adult idiopathic hypersomnia, a condition in which patients experience chronic excessive daytime sleepiness, sleep inertia, prolonged yet non-restorative nighttime sleep and naps, and cognitive impairment... |
|
Continue reading
|
|
|
|